Natalia Rompoti

692 total citations
26 papers, 326 citations indexed

About

Natalia Rompoti is a scholar working on Immunology, Dermatology and Pathology and Forensic Medicine. According to data from OpenAlex, Natalia Rompoti has authored 26 papers receiving a total of 326 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Immunology, 10 papers in Dermatology and 8 papers in Pathology and Forensic Medicine. Recurrent topics in Natalia Rompoti's work include Psoriasis: Treatment and Pathogenesis (12 papers), Dermatology and Skin Diseases (6 papers) and Autoimmune Bullous Skin Diseases (5 papers). Natalia Rompoti is often cited by papers focused on Psoriasis: Treatment and Pathogenesis (12 papers), Dermatology and Skin Diseases (6 papers) and Autoimmune Bullous Skin Diseases (5 papers). Natalia Rompoti collaborates with scholars based in Greece, Germany and Italy. Natalia Rompoti's co-authors include Dimitrios Rigopoulos, Konstantinos Theodoropoulos, Evangelia Papadavid, Stamatios Gregoriou, Joachim Klode, Joachim Dissemond, Andreas Körber, Electra Nicolaidou, Pelagia Katsimbri and Dimitrios Boumpas and has published in prestigious journals such as PLoS ONE, Journal of the American Academy of Dermatology and International Journal of Environmental Research and Public Health.

In The Last Decade

Natalia Rompoti

23 papers receiving 316 citations

Peers

Natalia Rompoti

IMMUN

DERMA

PFM

EPIDE

RHEUM

Richuan Zheng Japan

Aleksandra G. Florek United States

P. Regnault United States

Lisa Eisert Germany

Alison Potts Bleakman United States

Kamyar Farahi United States

Arvin Ighani Canada

S. Jazayeri United States

Toshihiro Ito Japan

Khalad Maliyar Canada

Richuan Zheng Japan

Natalia Rompoti

262 ×1.1

IMMUN

198 ×1.0

DERMA

69 ×0.7

PFM

76 ×0.8

EPIDE

61 ×1.3

RHEUM

Citations per year, relative to Natalia Rompoti Natalia Rompoti (= 1×) peers Richuan Zheng

Countries citing papers authored by Natalia Rompoti

Since Specialization

Citations

This map shows the geographic impact of Natalia Rompoti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Natalia Rompoti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Natalia Rompoti more than expected).

Fields of papers citing papers by Natalia Rompoti

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Natalia Rompoti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Natalia Rompoti. The network helps show where Natalia Rompoti may publish in the future.

Co-authorship network of co-authors of Natalia Rompoti

This figure shows the co-authorship network connecting the top 25 collaborators of Natalia Rompoti. A scholar is included among the top collaborators of Natalia Rompoti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Natalia Rompoti. Natalia Rompoti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Stefanaki, Irene, Natalia Rompoti, Marina Papoutsaki, et al.. (2025). Bimekizumab Treatment for Scalp Psoriasis: A 52‐Week, Real‐World, Retrospective Study. International Journal of Dermatology. 64(6). 1098–1100. 1 indexed citations

Rompoti, Natalia, Aikaterini Ι. Liakou, Andreas G. Tsantes, et al.. (2025). Systemic inflammation correlates with depression and lower quality of life in patients with hidradenitis suppurativa independent of disease severity. Archives of Dermatological Research. 317(1). 649–649. 1 indexed citations

Rompoti, Natalia, et al.. (2024). Single‐center experience with bimekizumab in psoriasis patients with previous exposure to interleukin‐17 inhibitors. International Journal of Dermatology. 64(6). 1092–1094.

Rompoti, Natalia, Konstantinos Kontoangelos, Anastasios V. Kouzoupis, et al.. (2024). Psychopathological Profile of Patients with Moderate-to-Severe Plaque Psoriasis and Its Correlation to DLQI: Results from a Prospective, Monocentric Clinical Study. Journal of Clinical Medicine. 13(21). 6424–6424. 1 indexed citations

Liakou, Aikaterini Ι., Andreas G. Tsantes, Eleni Routsi, et al.. (2024). Association between Inflammatory Markers and Psychometric Scores in Patients with Hidradenitis Suppurativa. Journal of Clinical Medicine. 13(19). 5795–5795. 1 indexed citations

Rompoti, Natalia, et al.. (2024). Switching within the class of IL ‐17 inhibitors for the treatment of plaque psoriasis: A real‐world retrospective study. Australasian Journal of Dermatology. 66(2). 101–104.

Tsiogka, Aikaterini, Stamatios Gregoriou, Alexander Stratigos, et al.. (2023). The Impact of Treatment with IL-17/IL-23 Inhibitors on Subclinical Atherosclerosis in Patients with Plaque Psoriasis and/or Psoriatic Arthritis: A Systematic Review. Biomedicines. 11(2). 318–318. 12 indexed citations

Rompoti, Natalia, et al.. (2022). Brodalumab in plaque psoriasis: Real‐world data on effectiveness, safety and clinical predictive factors of initial response and drug survival over a period of 104 weeks. Journal of the European Academy of Dermatology and Venereology. 37(4). 689–697. 19 indexed citations

Tsiogka, Aikaterini, Stamatios Gregoriou, Alexander Stratigos, et al.. (2022). The impact of treatment with IL-17/IL-23 inhibitors on subclinical atherosclerosis in patients with plaque psoriasis and/or psoriatic arthritis: a systematic review. 4 indexed citations

10.

Rompoti, Natalia, Konstantinos Kontoangelos, Christos Papageorgiou, et al.. (2022). Psychopathology and Alexithymia in Patients with Moderate-to-Severe Psoriasis: Development of a Novel Index with Prognostic Value. International Journal of Environmental Research and Public Health. 19(7). 4029–4029. 5 indexed citations

11.

Rigopoulos, Dimitrios, Natalia Rompoti, & Stamatios Gregoriou. (2021). Management of Nail Psoriasis. Dermatologic Clinics. 39(2). 211–220. 12 indexed citations

12.

Gregoriou, Stamatios, et al.. (2020). Treatment of nail psoriasis with calcipotriol/betamethasone dipropionate foam versus pulse dye laser: an unblinded, intra‐patient, left‐to‐right prospective study. Journal of the European Academy of Dermatology and Venereology. 34(9). e519–e520. 9 indexed citations

13.

Rigopoulos, Dimitrios, Robert Baran, Soumiya Chiheb, et al.. (2019). Recommendations for the definition, evaluation, and treatment of nail psoriasis in adult patients with no or mild skin psoriasis: A dermatologist and nail expert group consensus. Journal of the American Academy of Dermatology. 81(1). 228–240. 86 indexed citations

14.

Rompoti, Natalia, Pelagia Katsimbri, Dimitrios Boumpas, et al.. (2019). Real world data from the use of secukinumab in the treatment of moderate‐to‐severe psoriasis, including scalp and palmoplantar psoriasis: A 104‐week clinical study. Dermatologic Therapy. 32(5). e13006–e13006. 37 indexed citations

15.

Sondermann, Wiebke, Lara K. Leister, Natalia Rompoti, et al.. (2018). Unzureichender Tetanusimpfschutz bei Psoriasis und systemischer Immunsuppression: Ergebnisse einer retrospektiven Untersuchung an 101 Patienten. Der Hautarzt. 18(11). 141–146. 3 indexed citations

16.

Sondermann, Wiebke, Lara K. Leister, Natalia Rompoti, et al.. (2018). Unzureichender Tetanusimpfschutz bei Psoriasis und systemischer Immunsuppression. Der Hautarzt. 69(11). 922–927. 3 indexed citations

17.

Sondermann, Wiebke, et al.. (2017). Lymphopenia and CD4+/CD8+ Cell Reduction under Fumaric Acid Esters. Dermatology. 233(4). 295–302. 10 indexed citations

18.

Rompoti, Natalia, et al.. (2016). Purpura fulminans related to paroxysmal nocturnal haemoglobinuria. European Journal of Dermatology. 26(4). 397–398. 1 indexed citations

19.

Sondermann, Wiebke, Klaus Griewank, Bastian Schilling, et al.. (2015). Corticosteroids Augment BRAF Inhibitor Vemurafenib Induced Lymphopenia and Risk of Infection. PLoS ONE. 10(4). e0124590–e0124590. 5 indexed citations

20.

Rompoti, Natalia, et al.. (2011). Schmerzreduktion bei Patienten mit chronischem Ulcus cruris durch ein neu entwickeltes Morphingel. Der Hautarzt. 62(4). 280–286. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact